Medicare Enrolled

Dr. Alicia Lai, DPM

Primary Podiatric Medicine Podiatrist · Linwood, NJ
Low-engagement
222 NEW RD STE 205, Linwood, NJ 08221
6096532066
In practice since 2012 (14 years)
NPI: 1023372653 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lai? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lai

Dr. Alicia Lai is a primary podiatric medicine podiatrist in Linwood, NJ, with 14 years of NPI registration.

Between the years covered by Open Payments, Dr. Lai received a total of $4,262 from 31 pharmaceutical and/or device companies across 72 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in primary podiatric medicine podiatrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lai is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice $4,262 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$4,262
Total received (2018-2024)
Avg $609/year across 7 years
Top 19% in NJ for primary podiatric medicine podiatrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
72
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,083 (95.8%)
Other
Charitable contributions, space rental, and other categories
$179 (4.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$343
2023
$532
2022
$855
2021
$902
2020
$352
2019
$590
2018
$689

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Integra LifeSciences Corporation
$179
Averitas Pharma Inc.
$35
Amgen Inc.
$30
TREACE MEDICAL CONCEPTS, INC.
$28
Kerecis Limited
$24
Organogenesis Inc.
$22
Smith+Nephew, Inc.
$16
CashFlow Solutions, LLC
$9
Top 3 companies account for 71.1% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$497
Stryker Corporation
$478
Paragon 28, Inc.
$350
Smith+Nephew, Inc.
$315
Ortho Dermatologics, a division of Bausch Health US, LLC
$308
Integra LifeSciences Corporation
$297
GRT US Holding, Inc.
$264
Kerecis Limited
$130
Allergan Inc.
$125
Wright Medical Technology, Inc.
$118
Horizon Therapeutics plc
$116
Organogenesis Inc.
$116
Zimmer Biomet Holdings, Inc.
$116
Averitas Pharma Inc.
$116
ABBVIE INC.
$114
Bard Peripheral Vascular, Inc.
$114
Paratek Pharmaceuticals, Inc.
$107
Nevro Corp.
$104
Amniox Medical, Inc.
$101
WRIGHT MEDICAL TECHNOLOGY, INC.
$83
Trilliant Surgical LLC.
$61
Next Science LLC
$47
Amgen Inc.
$30
TREACE MEDICAL CONCEPTS, INC.
$28
Iroko Pharmaceuticals, LLC
$26
Cardiovascular Systems Inc.
$23
DePuy Synthes Sales Inc.
$22
Bioventus LLC
$21
Kowa Pharmaceuticals America, Inc.
$15
Smith & Nephew, Inc.
$14
CashFlow Solutions, LLC
$9
Top 3 companies account for 31.1% of all-time payments
Associated products mentioned in payments ›
ALLOGRAFT · AUGMENT INJECTABLE · CAPTURE · CARTIVA · COLLAGENASE SANTYL · DALVANCE · Exogen · Foot & Ankle-None · HALLU LOCK · Integra · Integra Dermal Regeneration Template · JUBLIA · KRYSTEXXA · Kerecis Omega3 SurgiClose · Kerecis Omega3 Wound · LAPIPLASTY SYSTEM · LUTONIX · LUZU · LYMPHA PRESS OPTIMAL PLUS(US) BT · N/A · NEOX · NUZYRA · No Associated Product · ORTHOLOC · Product Portfolio · Puraply · QUTENZA · Qutenza · SEGLENTIS · SONICANCHOR · Santyl · Senza · Supera peripheral stent system · SurgX · TENOTAC 2.0 · VARIAX · VIVLODEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a primary podiatric medicine podiatrist in Linwood?
Compare primary podiatric medicine podiatrists in the Linwood area by procedure volume, costs, and industry payment transparency.
Browse primary podiatric medicine podiatrists nearby

Geographic Context

Primary podiatric medicine podiatrists within 10 mi
2
Per 100K population
0.7
County median income
$76,819
Nearest hospital
SHORE MEDICAL CENTER
2.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lai is a primary podiatric medicine podiatrist, with low-engagement industry engagement in the top 19% of NJ peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Lai receive payments from pharmaceutical companies?
Yes. Dr. Lai received a total of $4,262 from 31 companies across 72 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Lai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →